Member Info for DShox

At 30 June.

Two operating businesses - StoneChecker (sale imminent) and IB Neuro (NIH grants cover 60% of development costs covered).

£7m cap at 5p. Nil debt. CEO owns 30%. Other director 6%. NT to buy and shorts unwinding.

Close StoneChecker deal with major, anticipate large re-rate.

Imaging Biometrics (IB) Neuro is more advanced re Brain Tumor imaging. What's interesting is how the same platform has been able to create products for stroke assessment and telemedicine. What I hadn't appreciated is that IB already has FDA approval?

The RNS does elude to a deeper partnership forming with whichever global major buys StoneChecker but why would IQ-AI sell IB now? That's its other operating subsidiary and so that's IQ-AI basically a cash shell with royalties. Great for shareholders but maybe too early?

Just finally, if I look at the twitter feed, the usual suspects were shorting this from 7.5p. I reckon these are unwinding now and that delayed trade on Friday was one of them.

All good posts.

I'd like to up skill myself in the industry and technology.

IQ-AI will know what the royalty expectations are to obviously work out fair value for the cash part. This detail should be made available when the deal is done so the market can rate it.

Selling StoneChecker completely removes the operating and marketing costs entirely but delivers ongoing pure revenue/profit. I guess then a PE ratio attaches to IQ-AI to drive a re-rate and tells the market IQ-AI no longer needs to issue "cap in hand" shares.

Anyone with any thoughts on "similar" deals or peer group comparisons? At the right point, it'd be good to see an investor presentation.

Trek, evidently the cash burn is several orders of magnitude below your 5th August expectations no? At the half year to 30 June there was £611k cash in the bank.

The 5th you said:

"If you look at the balance Dec 2019 it’s £865, 875. Admin costs are £859,171. So even without all the other expenses they are evens. Then factor in carry forward loss of £617k, zero tax liabilities (obviously) and allowing for same in revenues there really isn’t much cash left when you take in the spend from Dec 2019 to now."

I don't think you "freewheeling to a deal" can be used on the 5th and again yesterday.

I note your reference to a £2.75 five year grant to "subsidise revenue" and "(this may help)". Actually the number referenced in the half years is $2.8m. You also missed the $2.6m awarded in June. These are both NIH grants and together cover "60% of the development cost of IB" at current staffing. Very specific to IB and includes all costs, so wrong to separate R&D from administration costs.

You will do well to note IQ-AI intends to make further applications to NIH for additional grants in 2020 and following IB being recognised as the US 'national standard' in June, do you not see a situation where IB could be almost fully covered by grants? That would be an extraordinary achievement for a micro cap health tech co.

I note in your posting history you are partial to a short or two and frequent this type of stock. That's fine, it's a legal trade after all.

I think IQ-AI management would take exception to this being called a "lifestyle company". I see the complete opposite given director holdings of 36%, rapid development of StoneChecker and IB, and imminent sale of StoneChecker that will be transformational to the share price.

If you watch the Proactive interview, IQ-AI wants a more robust market cap so it can take advantage of acquisition opportunities.

Never rule out a raise from a micro cap, but not all raises are made equal.

Bogey cleared

Last chance to buy.
Please stay 2m apart.
Wear a mask.

If its exclusive, that manufacturer secures an advantage over its competitors = equals higher premium to IQ-AI. Given it's the StoneChecker operating business being sold, it is exclusive.

I picked up the logical reference in today's RNS about deepening the partnership beyond StoneChecker. So whoever it is, Siemens, GE, or Philips for example, IB seems next.

So is it grown up, responsible or sensible to respond to an excitable PI with misinformation?

I shall prepare your humble pie. It's in the oven.

Talked of childish remarks and then call people "the rampers"? Hmm.

Admit it, you gleefully posted $400k to influence the passing PI along with your 4p prediction (not happened).

You are not qualified to call the level at which individual PIs get excited or otherwise. 10p is still a bag so if that's your worst case, says alot eh.

So 10p is a disappointment? That's more than double. It rather says alot about where you thin

Calm down dear. I simply pointed out the presence of such tweets and posts and asked a question. If that degree of positivity upsets you so much, you must have alot riding on actively trolling IQAI across multiple platforms.

If this deal concludes and its multiples of the $400k you stated earlier, bagging the sp, will you admit I was right and you were hopelessly wrong?

I see you and your twitter IDs and crew are trolling overtime begging for sells. We all know MMs are creating a fake market and spread designed to spook sells. The deeper the dig, the greater the upside. Lets see whose right ;)

I think you are wasting your breath now. If it's a short you're unwinding from 7p or a Broker/MM you represent, PIs can read two fantastic RNSs and a transformational deal with a major about to land.

We have Trek a couple days ago suggesting a placing and today we find there's tonnes of cash in the kitty, new sales generation avenues, almost $5.5m of grants to IB Neuro (its other main business, and the more valuable), which potentially makes this co self-funded with share buybacks into the future. At £6.5m cap, the sp is a joke and to me, an easy bag.

I'm seeing chatter on Twitter plus a couple of posts removed here suggesting this deal progresses over the weekend. I know conversations have run for about 6 months with multiple expressions of interest (halted when lockdowns hit) and then in June we were down to 2 parties with one now signing an LOI to buy. The RNS said dd had commenced, which I assume is more of the legal stuff?

My problem is all mine are outside ISA. That's stuffed full. If I don't sell, tax man can't get his mits on the profit. So best to hold and yep, eventually see the Board calling in a massive payday.

NT to buy repeatedly last 3 days and 50 mins MMs didn't let PIs buy shares at 4.6-4.7p yesterday. Say no more about MMs being short, which has led to this desperate spread play. To many, it reinforces conviction to accumulate now.

Spend a bit of time on its website and you see a business IQ-AI is complementing. After StoneChecker, IB will be next with a major.

Just report the troll

Keep smiling. Look at the intraday chart. No sells to justify this third day of MM drop tactics. No doubt we will get repeated periods of NT to buy. We had almost an hour at 4.6-4.7p yesterday. I am minded to report this to regulators to review MM behaviour.

Reported Wolves. I suggest others do the same.